// App-Quantinova.ai

P4-01-17 : Expression of circulating tumor cells (CTC) and CK-19 mRNA (CK19) as prognostic factors in heavily pretreated metastatic breast cancer

Researchers

Presenter

  • Morales S

Principal Investigators

  • Velasco A

  • Vidal JSerrate AValls J

  • Samame JC

  • Gisbert R

  • Moral D

  • Llombart A

  • Salud A

  • Matias-Guiu X

Medical Centers

  • Institut de Recerca biomedica-IRB, Lleida, Spain

  • Hospital Arnau de Vilanova, Valencia, SpainHospital Arnau de Vilanova, Lleida, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Cytokeratin 19

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved